Is Home Depot Stock a Buy, Hold, or Sell? A Comprehensive Analysis

PUBLISHED Apr 25, 2025, 7:40:41 PM        SHARE

img
imgjp_dividends on YouTube

Welcome back, investors and stock enthusiasts! Today, we're diving deep into Home Depot (HD), the go-to retailer for all things home improvement. We'll analyze whether it's a buy, hold, or sell by examining its business model, financials, dividend performance, and valuation. If you're keen on dividend stocks or have others you'd like analyzed, feel free to share them in the comments below. Don’t forget to like and subscribe for more content like this!

Home Depot: How They Make Money

Home Depot has established itself as the premier destination for home improvement products, ranging from appliances to garden supplies, blinds, electrical equipment, and outdoor furniture. Whether you're upgrading your home or tackling DIY repairs, Home Depot caters to homeowners and contractors alike. The company's ability to attract repeat customers—those who regularly shop for home improvement needs—has been a cornerstone of its success.

HD Stock Performance

2025 has started strong for Home Depot, but a closer look at its performance reveals mixed results:

  • One-Year Performance: Up 14.7%, lagging behind the S&P 500’s impressive 24% gain.
  • Five-Year Performance: Nearly on par with the S&P 500, excluding dividends reinvested. Factoring in dividends, the gap likely narrows further. While Home Depot stock has experienced notable dips recently, these create attractive buying opportunities for long-term investors seeking a lower average cost.

Home Depot’s Financials

Financial stability is crucial, and Home Depot shows strong signs of consistent growth:

Revenue:

  • Over the past decade, HD has demonstrated steady revenue growth, now reaching $154 billion in trailing 12 months.
  • Post-2020, growth has slowed slightly but remains solid with promising recovery signs in recent quarters.

Net Income:

  • While revenue bounced back, net income tells a slightly different story with a flattening trend rather than robust growth. However, recent quarters show improvements, hinting at a potential turnaround.

Free Cash Flow:

  • The star metric! Free cash flow continues its clear upward trend, with strong recovery in 2024 following slower years in 2022 and 2023.

Overall, Home Depot’s financial health is strong, boasting a PE ratio of 27.7, suggesting it is moderately priced.

Key Financial Metrics

Home Depot showcases robust financial metrics that underline its healthy operations:

  • Net Profit Margin: 9.45%—a solid range for a retailer.
  • Return on Assets (ROA): 15.3%—well above the desired threshold of 5%.
  • Return on Equity (ROE): An impressive 44%, crushing expectations!

One caveat is the company’s reliance on leverage, with significant debt of $63 billion compared to only $1.5 billion in cash. While not unusual for the sector, investors should keep an eye on this.

Dividend Performance

Home Depot’s dividend stats further highlight its attractiveness for income investors:

  • Yield: 2.2%—competitive within its sector.
  • Payout Ratio: 60.4%—suggesting dividends are sustainable.
  • Five-Year Dividend Growth Rate: 10.59%—strong annual growth.
  • Dividend Safety: Free cash flow payout ratio of 46.93%, ensuring ample room for future increases.

Although the 10-year dividend growth rate (16.95%) exceeds the five-year rate, growth has moderated slightly. Despite this, consistent 10% annual increases make Home Depot a reliable dividend stock.

Valuation Insights

Using Discounted Cash Flow (DCF) and other models, Home Depot appears fairly valued:

  • DCF Intrinsic Value: $365
  • Simply Wall Street Estimate: $432
  • Current Trading Price: $409—slightly above intrinsic value, signaling potential for modest downside but stability overall.

Conclusion: Is Home Depot a Buy?

Home Depot offers investors a robust and healthy business model with consistent revenue growth, stable dividends, and reliable free cash flow. However, its net income trends and valuation suggest limited upside potential in the near term. Long-term, Home Depot stands as a dependable option for dividend-focused portfolios and those who believe in the sustained growth of the home improvement sector.

Would you invest in Home Depot, or do you prefer a diversified dividend ETF for higher yields? Share your thoughts below, and let’s discuss!

https://youtu.be/7I75n3aHVrI?si=jlQOluWWzQDpkQFb



Sound investments
don't happen alone

Find your crew, build teams, compete in VS MODE, and identify investment trends in our evergrowing investment ecosystem. You aren't on an island anymore, and our community is here to help you make informed decisions in a complex world.

More Reads
Are dividend stocks good for passive income?
Image

Dividend stocks are shares of companies that regularly distribute a portion of their earnings to shareholders in the form of dividends. These payouts often serve as an incentive for investors seeking steady income, making dividend stocks a popular choice for passive income strategies.

The Big Flaw of the P/E Ratio (and How to Fix it)
Image

The stock market's current turbulence has left retail investors searching for reliable indicators to guide them back into equities. Among these indicators, the price-to-earnings (P/E) ratio stands out as one of the most commonly discussed metrics, having been a cornerstone of investing for nearly a century.

Lululemon: Undervalued Opportunity or Value Trap?
Image

Ticker symbol LULU has seen a significant drop of over 20%, leaving investors questioning whether Lululemon represents an undervalued opportunity or a value trap.

The Trade Desk (Ticker: TTD): A Look at Explosive Growth and Unique Offerings
Image

Ticker symbol TTD has skyrocketed over 80% in the past year, making The Trade Desk a standout performer in the stock market. With a remarkable 102% year-over-year net income growth and consistent margin expansion, this digital advertising powerhouse is revolutionizing the way businesses approach marketing campaigns.

Novo Nordisk: A Stock Under Pressure, but Is It a Value Opportunity?
Image

Novo Nordisk, the Danish pharmaceutical giant, has experienced a significant price dip, falling over 40% from its all-time highs in June 2024. This decline stems from several challenges, including the entrance of competitors offering weight-loss drugs, less successful clinical trial results than anticipated, and heightened uncertainty due to new U.S. political administration policies and potential tariffs on foreign pharmaceutical companies.

ASML Stock: Balancing Risk and Reward Amid Cyclicality
Image

Good day, fellow investors! ASML Holding (ASML) has faced a challenging stretch in recent months, with the stock down 42% over the last 10 months. Tariff concerns and market uncertainty have weighed heavily on its price.

BHP Stock: Long-Term Potential Amid Cyclical Downturns
Image

Good day, fellow investors! BHP Group (BHP) has faced a challenging period, with its stock down 30% over the last two years. Yet, the fundamentals remain strong—cash flows are healthy, dividends are consistent, and the market capitalization stands at a notable $126 billion.

STAG Industrial Stock: Is It Time to Invest?
Image

The stock market’s recent volatility has impacted all sectors, including Real Estate Investment Trusts (REITs). Among those facing a downturn is STAG Industrial (STAG), with its stock down approximately 25% from its 52-week high and nearing its 52-week low.

ARCC Stock: A Dividend Investor’s Dream?
Image

If you’re a dividend enthusiast, Ares Capital Corporation (ARCC) might already be on your radar. Known for its stellar dividend yields, ARCC has recently taken a hit, with its stock falling 15-20% from its year-to-date high.

LTC Stock Analysis: Is This Real Estate Investment Trust (REIT) Worth Your Attention?
Image

The stock market has been tumultuous lately, making it crucial for investors to seek out promising opportunities. One such contender is LTC Properties, Inc. (NYSE: LTC), a REIT specializing in healthcare facilities such as assisted living and skilled nursing properties.

Eli Lilly Stock: Analyzing its Valuation and Future Potential
Image

Eli Lilly (NYSE: LLY), a pharmaceutical giant with a market cap of $658 billion, has achieved impressive growth in recent years, primarily driven by its diabetes drugs, Mounjaro and Trulicity. But with a current stock price of $732, is Eli Lilly overvalued, or does it present an opportunity for long-term investors? Let’s break down the numbers and evaluate its valuation.

Pfizer Stock: A Deep Dive into Valuation and Investment Potential
Image

When it comes to the pharmaceutical industry, Pfizer stands tall as a legacy company with a rich history of innovation. However, its recent financial performance and stock price movements have left investors questioning its valuation. At a market cap of $124 billion and a trading price of $22 per share, is Pfizer undervalued, or does the dip signal deeper challenges?

Is Sanofi Stock Trading at an Undervalued Price? Here's What You Need to Know
Image

Investing in pharmaceutical stocks often means betting on innovation and consistent cash flow. With a strong market presence and a robust portfolio, Sanofi is no exception. But is it currently undervalued or an opportunity waiting to be seized? In this detailed analysis, we’ll dissect Sanofi’s financial statements and ratios to determine whether this large-cap stock should be on your radar.

Unlocking the Value of Boyd Gaming Stock: Is It a Buy or Sell?
Image

In the ever-evolving world of investing, evaluating stocks to determine their worth and potential can be as thrilling as a game of chance at a casino. Boyd Gaming Corporation (NYSE: BYD), a prominent player in the gaming and hospitality industry, is no exception.

Why Miners Are Losing Faith, But MicroStrategy Holds Strong: A Deep Dive into CleanSpark, Iron, and MARA
Image

The cryptocurrency landscape is no stranger to volatility, but recent developments in the Bitcoin mining sector have sparked heated debates among investors. With miners like CleanSpark making controversial strategic shifts and MicroStrategy steadfastly holding its Bitcoin, the industry is at a pivotal crossroads.

Why HIMS is a Recession-Proof Investment: Essential, Affordable, and Growing
Image

When economic uncertainties arise, investors tend to react by selling stocks across the board. Yet, there are companies that not only weather recessions but thrive during them. **HIMS & HERS Health Inc.**, a telehealth pioneer, stands out as one such example. Here's why HIMS remains a compelling investment, even in the face of economic downturns.

Pfizer Stock: Analyzing Opportunities Amid a 63% Decline
Image

Pfizer Inc. (NYSE: PFE) has experienced a dramatic decline in its stock price, plummeting 63% from its all-time high. With the dividend yield now approaching 8%, many investors are evaluating whether this is a lucrative buying opportunity or a potential trap.

Visa: The Ultimate Tariff Stock to Watch Amid Economic Shifts
Image

Economic uncertainties often spark debates around the most resilient stocks in the face of inflation and evolving tariff policies. Amid such volatility, Visa Inc. (NYSE: V) emerges as a standout player, not just surviving but thriving in inflationary periods.

SOFI and Using a Put Selling Strategy
Image

In recent times, SoFi Technologies Inc. (NASDAQ: SOFI) has witnessed a sharp decline in its stock price. From trading at $18 to falling below $10, investors are faced with questions about what lies ahead in a market riddled with volatility.

Is "The Low" In ?
Image

stock market commentary

Resources for Publishers
Resources for New Investors
Boosted with BossCoin
Top Investors
user_profile
Tom Hamilton
user_profile
Wise Intelligent
user_profile
Mark Robertson
user_profile
Kevin Matthews II
user_profile
Akeiva Ellis
user_profile
Brendan Dale
user_profile
Kenneth Chavis IV
user_profile
Sharita Humphrey